Severe Malaria
23
4
4
14
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 23 trials
100.0%
+13.5% vs benchmark
17%
4 trials in Phase 3/4
14%
2 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (23)
To Evaluate Efficacy, Safety, Tolerability and PK of Intravenous Cipargamin in Participants With Severe Plasmodium Falciparum Malaria
Host Immune and Metabolic Determinants of Sexual Conversion in Plasmodium Parasites IMMETASEX
Severe Malaria in Remote Areas- Closing the Evidence Gap
Clinical Prediction Models for Pediatric In-Hospital Death Risk in Congolese Severe Malaria Children Using Machine Learning Based-Algorithms
PDMC Implementation Trial in Kenya
Platelet-Directed Whole Blood Transfusion Strategy for Malaria
Monoclonal Antibodies in Children With Severe Anaemia or Severe Malaria to Prevent Malaria After Hospital Discharge
Post-discharge Malaria Chemoprevention Implementation Trial in Benin
Enhancing Pediatric Acute Care Through Adaptive E-Learning and In-Person Skills Practice in Tanzania
Study to Compare Feasibility of 1-step Injectable Artesunate vs. Conventional 2-step Injectable Artesunate
Effect of Paracetamol on Kidney Function in Severe Malaria
Association of Diabetes and Metabolic Syndrome With Severe Malaria in Cameroon
Lung Ultrasound in Children With Severe Malaria
Clinical Decision Support in Non-typhoidal Salmonella Bloodstream Infections in Children
Very Severe Malaria Treated by Intravenous Artesunate
Monitoring of Molecular Markers of Artemisinin Resistance Through Repeated Cross-sectional Assessments in DR Congo, Nigeria and Uganda
Severe and Cerebral Malaria Investigated Through Host Metabolomics
Evaluation of Oral Activated Charcoal on Antimalarial Drug's Ability to Kill Parasites in Malian Children With Malaria
Examination of Protective Factors Against Severe Malaria
Severe Malaria and Anti-malarial Drug Resistance in Cambodia